Alex Azar Quotes

And there are lots of drug companies that are working on cure or medicine.

We entered into the pharmaceutical industry in 1988, and since then, we have grown significantly on the back of a growing demand in India for pharmaceutical products.

On the third stage is used for medicine, it is not known to the public.

There are opportunities in the pharmaceutical industry, the insurance industry, so yes back home we are talking about investment opportunities in Morocco for various sectors of our economy and we will continue to do that.

There's always going to be the need for new medications, better medications.

In general, drug companies are reasonably good at developing new treatments, and there's also a lot of good in the industry.

Medicines are unusual commodities. Important drugs can save the lives and protect the health of millions. Their consumption can bring huge benefits, by helping patients to avoid infection and preventing serious damage to the economies of families, nations and even humanity at large.

I'd like to focus on my life on creating new medicines for people who are suffering from rare disease.

Cadila, India's sixth-largest drugmaker by sales, spent $250 million developing Lipaglyn, a new chemical entity or new discovery, and aims to spend another $150 million to $200 million to launch the drug outside India.

If you look at the world's top 50 drugs being sold today, they are being marketed and sold by companies that did not invent them. I respect patents. I'll pay a royalty. But I shouldn't be denied the right to produce drugs for poor people at reasonable prices.

One of the things that launched the strength in biotech is when the pharmaceutical industry itself got a little slow.

While I recognize the great value and importance of prescription drugs and strongly support a continued U.S. focus on pharmaceutical research and development, our nation's seniors cannot be asked to subsidize the drug costs of other wealthy industrialized nations any longer.

No pharmaceutical company is making money by selling biological knowledge - they make money by selling chemicals. So getting as much of that knowledge as possible into the efficiency of the Web-commerce world is going to make it faster to find those chemicals.

We have 28,000 drug patents held by American universities that are not being developed.

It’s our tax dollars that fund the initial research for these molecules that get transferred to corporations. We have an investment here… We end up paying for our drugs twice. We pay for the initial development through our tax dollars. And then when it goes on the market we pay their inflated prices.

The pharma industry is one of the few industries that comes up every year and brags about how much worse they got - like, now it costs $2 billion to make a drug, and it was a billion 5 years ago.

I fell in love with the science at Merck.

I think Trump's going to make it easier to be a drug company in America.

I would say that the pharmaceutical industry is hyper-competitive from a global perspective.

I really was inspired by the possibility of more directly being involved in the development of drugs myself.

I believe the pharma company of the future isn't going to be old-school.

If my drug Ragaglitazar had been successful, we would have been getting royalties of thousands of crore rupees every year.

In the pharma space, we have been growing both organically as well as through acquisitions.

The United States has an active pharmaceutical industry that has brought huge benefits to the U.S. public. Most Americans, who benefit from these advances, have little understanding of how difficult it is to create an important new medical therapy and make it available to improve public health.

We don't argue if drug companies create drugs that can cure humans and charge lots of money for them, even though we all have these diseases. It will be pretty hard to make a different argument for genes.